3rd International Congress on Mobile Devices and Seizure Detection in Epilepsy
October 28 - 30, 2021
Come visit us at Stand 9 in the main hall where we can give you a personal live demo and answer any questions you might have.
We have 6 NEL members attending over the course of the congress who all look forward to welcoming you! Don’t forget to visit our booth - you won’t leave empty handed. :)
Chief Executive Officer
Chief Commercial Officer
Chief Technology Officer
Business Development Manager
Country Manager - UK
Visit our booth and get your own eco-friendly plantable seed pencil or if you prefer to schedule time to meet with one of our representatives at the congress, please fill up the form below.
We can’t wait to see you there!
Get in touch with us and fill up this form to book a time with us during the congress
14th European Epilepsy Congress
Palexpo, Geneva, Switzerland Saturday 9th July 2022 to Wednesday 13th July 2022 Neuro Event Labs is happy to announce that we will be attending the 14th European Epilepsy Congress (EEC) (formerly European Congress on Epileptology or ECE) organised by International League Against Epilepsy (ILAE). This event will take place from 9 - 13 July 2022 at Palexpo, Geneva, Switzerland.
Neuro Event Labs at AES 2021, Chicago, IL
The American Epilepsy Society’s Annual Meeting is the largest gathering on epilepsy in the world. Meet Neuro Event Labs at Booth #1725 where we can give you a personal live demo and answer any questions you might have. December 3-7 Booth 1725, McCormick Place – West Building, Chicago, IL We have 5 NEL members attending over the course of the meeting who all look forward to welcoming you.
Neuro Event Labs Announced MedTech Veteran Rod Williams as CEO for NEL Inc.
Neuro Event Labs is a leading AI Motion Diagnostics and Digital Health company. Neuro Event Labs is happy to announce a strategy change toward worldwide development with the appointment of Rodney (Rod) J. Williams as Chief Executive Officer of Neuro Event Labs, Inc., the company’s U.S. subsidiary. Nelli® has been granted Breakthrough Device Designation by the FDA and is an investigational device in the USA.